DROSTANOLONE ENANTHATE BY HILMA BIOCARE

Injectable Oily Solution

DRUG COMPOSITION

1 mL of solution contains:
 - active substance: drostanolone enanthate 200 mg;
 - auxiliary substances:

DRUG DESCRIPTION

Transparent oily solution, from yellow to light yellow color, with characteristic smell.

PHARMACEUTICAL FORM

Injectable oily solution.

PHARMACEUTICAL GROUP AND ATC CODE

Androgen; Anabolic Steroid; Androgen Ester.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 8 Days
Routes ofadministration: intramuscular injection
Dosage forms: (Men): 400-600 mg/week; (Women): -
Acne: yes
Water retention: no
High blood pressure: no
Hepatotoxicity: low
Aromatase: no
Decreased HPTA function (own testosterone production): yes
Anabolic activity: 62%
Androgenic activity: 25%
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

Injectable oily solution 200 mg / 1 mL in 10 mL Vial vials.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

July 2019

NAME AND ADDRESS OF THE MANUFACTURER

Hilma Biocare
Europe